Guardant Health and Zephyr AI have partnered to advance the discovery of novel cancer biomarkers, as more precise tumour ...

Real-world data (RWD) is an asset for vaccine research, safety monitoring, and education efforts, and is essential toward ...

GSK has acquired the rights to Syndivia’s preclinical antibody drug conjugate (ADC), which is in development for prostate ...

Eli Lilly has agreed to acquire eye disease specialist Adverum Biotechnologies, bucking a recent trend of big pharma ...

Chugai has signed a definitive stock agreement to purchase Japan-based Renalys Pharma, augmenting its kidney disease ...

Novartis has signed an agreement for the acquisition of all the outstanding shares of US-based Avidity Biosciences.

Zavodnick told Pharmaceutical Technology that Excellergy plans to initiate an ex-US Phase I study of its lead ECRI candidate, a monoclonal antibody, in Q1 2026, with the goal of being ready for Phase ...